Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Total 13F shares
-
52,966,754
-
Share change
-
+15,107
-
Total reported value
-
$7,964,797,275
-
Put/Call ratio
-
116%
-
Price per share
-
$150.52
-
Number of holders
-
554
-
Value change
-
-$132,268,915
-
Number of buys
-
248
-
Number of sells
-
369
Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q1 2025
As of 31 Mar 2025,
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) was held by
554 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,966,754 shares.
The largest 10 holders included
VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., UBS Group AG, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, STATE STREET CORP, Allspring Global Investments Holdings, LLC, GEODE CAPITAL MANAGEMENT, LLC, Impactive Capital LP, and Invesco Ltd..
This page lists
557
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.